ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
5.04
+0.17 (3.39%)
Nov 21, 2024, 12:29 PM EST - Market open
ImmunityBio Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$17.38
Upside
+244.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +495.24% | Nov 19, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +495.24% | Nov 12, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +495.24% | Oct 23, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $6 → $4.75 | Hold | Maintains | $6 → $4.75 | -5.75% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | +19.05% | Apr 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | -0.79% | Mar 25, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $10 → $4 | Buy → Hold | Downgrades | $10 → $4 | -20.63% | May 12, 2023 |
| Jefferies | Jefferies | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +58.73% | Aug 3, 2022 |